Cardiovascular disease scholarly articles
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cardiovascular Disease: A Comprehensive Overview
Global Burden of Cardiovascular Diseases
Cardiovascular diseases (CVDs) are the leading cause of global mortality, encompassing conditions such as ischemic heart disease, stroke, heart failure, and peripheral arterial disease. The World Health Organization (WHO) reported that nearly one-third of all deaths in 2019 were due to myocardial or vascular diseases, with myocardial infarction and stroke accounting for 85% of these deaths. The prevalence of CVDs continues to rise, driven by various risk factors and lifestyle changes.
Inflammation and Oxidative Stress in Cardiovascular Disease
Chronic inflammation and oxidative stress are major contributors to the development and progression of CVDs. Inflammatory cells contribute to vascular oxidative stress, which is closely linked to atherosclerosis and other cardiovascular conditions. Established therapies with immunomodulatory properties have shown protective cardiovascular effects by normalizing oxidative stress. Large-scale clinical trials have demonstrated that specific anti-inflammatory therapies can reduce cardiovascular mortality in patients with atherosclerotic disease.
Cardiovascular Disease in South Asian Migrants
South Asian migrants to high-income nations exhibit a significantly higher burden of coronary artery disease (CAD) compared to Europids, with a prevalence 1.5-2 times greater. Factors such as increased abdominal obesity, type 2 diabetes mellitus, and dyslipidemia are primary drivers of this excess burden. Lifestyle changes post-immigration, including sedentary behavior and dietary modifications, further exacerbate these risks.
Environmental Factors and Cardiovascular Disease
Environmental exposures, including ambient air pollution and heavy metals like arsenic, cadmium, and lead, significantly contribute to the development and severity of CVDs. These exposures can initiate or exacerbate pathophysiological processes such as blood pressure control, lipid metabolism, and vascular function. Reducing environmental exposures could substantially lower the global burden of CVD-related death and disability.
Diabetes and Cardiovascular Disease
Type 2 diabetes is a major risk factor for CVD, significantly increasing the risk of cardiovascular events and mortality. Diabetic individuals, particularly those with macroalbuminuria, face a much higher risk of CVD compared to non-diabetics. LDL cholesterol and albuminuria are critical targets for preventive strategies in diabetic populations.
Genetic Factors in Cardiovascular Disease
Cardiovascular diseases have a strong genetic component, with many conditions being heritable. Advances in next-generation sequencing and the use of pluripotent human cells have enhanced our understanding of the genetic variations contributing to CVDs. However, challenges remain in translating genomic localization into mechanistic insights.
Cardiovascular Disease in Dialysis Patients
Patients with end-stage renal disease (ESRD) on hemodialysis (HD) face a significantly higher risk of CVD, with mortality rates 20 times higher than the general population. Non-traditional risk factors such as chronic volume overload, anemia, and oxidative stress play crucial roles in this increased risk. Understanding these factors is essential for developing effective prevention and treatment strategies.
Cardiovascular Disease in Childhood Cancer Survivors
Survivors of childhood cancer are at increased risk of CVD due to treatment exposures like anthracycline chemotherapy and chest-directed radiation therapy. Personalized risk prediction models and screening strategies are being developed to manage this risk. Ongoing prevention trials aim to mitigate cardiovascular risk across the survivorship spectrum.
Immune System and Cardiovascular Disease
The immune system plays a critical role in the development and progression of many cardiovascular diseases. Inflammation is a key factor in conditions such as atherosclerosis and atrial fibrillation. Advances in understanding the role of specific immune cells and inflammatory processes have opened new avenues for therapeutic interventions. Anti-inflammatory therapies are being explored for their potential to treat various cardiovascular conditions.
Conclusion
Cardiovascular diseases remain a leading cause of global morbidity and mortality, driven by a complex interplay of genetic, environmental, and lifestyle factors. Advances in understanding the roles of inflammation, oxidative stress, and genetic predispositions are paving the way for more effective prevention and treatment strategies. Continued research and multidisciplinary collaborations are essential to combat the growing burden of CVDs worldwide.
Sources and full results
Most relevant research papers on this topic